A detailed analysis of online pharmacy characteristics to inform safe usage by patients

Alwon, Bassam M., Solomon, Gennifer, Hussain, Faseeha and Wright, David (2015) A detailed analysis of online pharmacy characteristics to inform safe usage by patients. International Journal of Clinical Pharmacy, 37 (1). 148–158. ISSN 2210-7703

[thumbnail of On-line pharmacy research. 10.1007_s11096-014-0056-1]
PDF (On-line pharmacy research. 10.1007_s11096-014-0056-1) - Draft Version
Download (1MB) | Preview


Background: Evidence suggests that consumers potentially put themselves at risk when purchasing medicines on-line. Whilst logos provided by regulators may provide some level of reassurance there may be other indicators which could be used by consumers to identify those websites which may be safely used. Objectives: Identify characteristics of on-line pharmacies which are related to whether websites are regulated or non-regulated and those characteristics which could be used by patients to increase the likelihood of accessing regulated sites. Setting: Online pharmacies which supply diazepam, fluoxetine and simvastatin. Methods: Using piloted search terms via Google and Yahoo search engines, identified websites were screened for regulatory status, adherence to regulatory standards, administrative requirements, clinical assessment requirements and additional details deemed to be of relevance to a user. Characteristics of regulated and non-regulated (defined as those with an absence of a correctly linked regulatory logo) websites were compared to identify differences which could be used to improve patient safety. Main outcome measure: Regulatory status, adherence to regulatory standards, quality of information provision, barriers to medicines access. Results: 113 websites sold diazepam, fluoxetine and simvastatin; were identified within the first 100 results. Less than quarter were found to be regulated online pharmacies. 80 websites were willing to sell the medication without a prescription. The unregulated internet pharmacy websites (defined as those with an absence of a correctly linked regulatory logo) were found to adhere more closely to the clinical criteria, were less significantly likely to disclose a contact name and address, telephone number of the pharmacy or demand a prescription prior to sale (P\0.05, Fisher’s Exact). Conclusions: The three prescription-only medicines which are liable to abuse, have potentially serious interactions and require counselling to ensure patient safety are readily available via the internet. When purchasing medicines via this route UK consumers should be made aware of the importance of regulatory logos and additionally should ensure that the seller can be meaningfully contacted by the contact details provided. The provision of clinical information should not be used alone as an indication of the seller’s provenance.

Item Type: Article
Uncontrolled Keywords: counterfeit medicines,falsified medicines,on-line pharmacy,internet,abuse,consumer
Faculty \ School: Faculty of Science > School of Pharmacy
UEA Research Groups: Faculty of Science > Research Groups > Medicines Management (former - to 2017)
Faculty of Science > Research Groups > Patient Care
Depositing User: Pure Connector
Date Deposited: 02 Feb 2015 16:06
Last Modified: 22 Oct 2022 02:05
URI: https://ueaeprints.uea.ac.uk/id/eprint/51755
DOI: 10.1007/s11096-014-0056-1


Downloads per month over past year

Actions (login required)

View Item View Item